Role of Vanilloid Receptors in Diabetic Peripheral Neuropathy
Role of Vanilloid Receptors in Diabetic Peripheral Neuropathy
批准号:
7682748
负责人:
LOUIS S PREMKUMAR
金额:
$7.28万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-12-01 至 2010-08-31
关键词:
AffectAfferent NeuronsAgonistAnimalsAreaBlood VesselsBlood flowBurning PainCALCA geneCalcitonin Gene-Related PeptideCardiovascular systemCell physiologyChemicalsComplications of Diabetes MellitusDiabetes MellitusDiabetic mouseDiseaseElectrophysiology (science)Endothelial CellsEsthesiaExhibitsFamilyGlucoseHypersensitivityInflammatoryIon ChannelMechanicsMediatingMesenteric ArteriesModelingNerveNeuronsNociceptionNon-Insulin-Dependent Diabetes MellitusOrganPainPatientsPeripheralPeripheral NervesPeripheral Nervous System DiseasesPhasePhenotypePreparationProcessRattusResiniferatoxinReverse Transcriptase Polymerase Chain ReactionRoleS100A12 geneSensorySiteSkinSpinalSpinal CordStreptozocinSynapsesSynaptic TransmissionTechniquesTherapeutic InterventionThermal HyperalgesiasTimeVanilloidWestern Blottingafferent nervecapsaicin receptorcentral sensitizationdiabeticdiabetic ratdorsal hornexperiencehuman S100A12 proteinneuronal cell bodypreventreceptorresearch study
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Diabetic peripheral neuropathy (DPN) is characterized by altered chemical, thermal and mechanical sensitivities.
Since Transient Receptor Potential (TRP) family of ion channels transduces chemical, thermal and mechanical
sensation, it is likely that TRP Vanilloid 1 (TRPV1) and TRP Vanilloid 4 (TRPV4) are involved DPN. In this study,
we will use streptozotocin-induced diabetic (SD) rats as a model for type1 diabetes mellitus (T1DM) and Zucker
diabetic fatty (ZDF) rats as a model for type 2 diabetes mellitus (T2DM). The expression and function of
nociceptive ion channels TRPV1 and TRPV4 will be studied. In preliminary experiments, using mouse models of
diabetes, we have found that diabetic mice exhibit an initial phase of thermal hyperalgesia followed by a phase of
thermal hypoalgesia. The mechanisms underlying these phenotypes will help us understand the hypersensitivity
and the marked sensory loss observed in patients with diabetes. In Aim 1, we will determine the expression and
function of TRPV1 and TRPV4 in peripheral nerve terminals and the DRG neuronal cell bodies. In spite of sensory
loss as a result of nerve terminal degeneration, some patients experience burning pain sensation. This suggests
that peripheral sensitization is not responsible for the pain, and central sensitization is more likely to be involved at
spinal and supraspinal sites. In the second aim, we will determine the expression and function of TRPV1 and
TRPV4 at the spinal dorsal horn and determine their role in the modulation of synaptic transmission. Then, we will
determine whether targeting TRP channels in the spinal cord can relieve hypersensitivity. DPN also affects
internal organs and blood vessels innervated by sensory nerves mediating efferent nonsensory functions. In the
third aim, we will determine the expression and function of TRPV1 and TRPV4 in blood vessels and examine the
functional consequence(s) by studying the changes in the vascular tone and endothelial cell functions. Findings
from this study will increase our understanding how sensory and nonsensory functions of TRPV1 and TRPV4
impact the disease process. The complications of DPN can be prevented/delayed by maintaining normal glucose
levels and expression and function of TRP channels by therapeutic interventions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Novel Approach for Chronic Pain Treatment Using Resiniferatoxin
-
批准号:7664827
-
项目类别:
-
资助金额:$29.87万
-
财政年份:2009
-
负责人:LOUIS S PREMKUMAR
-
依托单位:
A Novel Approach for Chronic Pain Treatment Using Resiniferatoxin
-
批准号:8077896
-
项目类别:
-
资助金额:$26.55万
-
财政年份:2009
-
负责人:LOUIS S PREMKUMAR
-
依托单位:
A Novel Approach for Chronic Pain Treatment Using Resiniferatoxin
-
批准号:8473195
-
项目类别:
-
资助金额:$25.49万
-
财政年份:2009
-
负责人:LOUIS S PREMKUMAR
-
依托单位:
A Novel Approach for Chronic Pain Treatment Using Resiniferatoxin
-
批准号:8267070
-
项目类别:
-
资助金额:$26.55万
-
财政年份:2009
-
负责人:LOUIS S PREMKUMAR
-
依托单位:
A Novel Approach for Chronic Pain Treatment Using Resiniferatoxin
-
批准号:7869275
-
项目类别:
-
资助金额:$27.37万
-
财政年份:2009
-
负责人:LOUIS S PREMKUMAR
-
依托单位:
Vanilloid Receptors in Diabetic Peripheral Neuropathy
-
批准号:6930403
-
项目类别:
-
资助金额:$25.74万
-
财政年份:2004
-
负责人:LOUIS S PREMKUMAR
-
依托单位:
Vanilloid Receptors in Diabetic Peripheral Neuropathy
-
批准号:6820139
-
项目类别:
-
资助金额:$25.74万
-
财政年份:2004
-
负责人:LOUIS S PREMKUMAR
-
依托单位:
Vanilloid Receptors in Diabetic Peripheral Neuropathy
-
批准号:7090665
-
项目类别:
-
资助金额:$25.14万
-
财政年份:2004
-
负责人:LOUIS S PREMKUMAR
-
依托单位:
Endogenous Activators of Vanilloid Receptor
-
批准号:6361225
-
项目类别:
-
资助金额:$20.33万
-
财政年份:2001
-
负责人:LOUIS S PREMKUMAR
-
依托单位:
Endogenous Activators of Vanilloid Receptor
-
批准号:6540518
-
项目类别:
-
资助金额:$17.63万
-
财政年份:2001
-
负责人:LOUIS S PREMKUMAR
-
依托单位:
Endogenous Activators of Vanilloid Receptor
-
批准号:6639818
-
项目类别:
-
资助金额:$17.63万
-
财政年份:2001
-
负责人:LOUIS S PREMKUMAR
-
依托单位:
Endogenous Activators of Vanilloid Receptor
-
批准号:6750989
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2001
-
负责人:LOUIS S PREMKUMAR
-
依托单位:
Endogenous Activators of Vanilloid Receptor
-
批准号:6770055
-
项目类别:
-
资助金额:$17.63万
-
财政年份:2001
-
负责人:LOUIS S PREMKUMAR
-
依托单位:
海外基金